¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ligand chromatography"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ligand binding site
    ¸®°£µå°áÇÕºÎÀ§
  • receptor-ligand interaction
    ¼ö¿ëü¸®°£µå»óÈ£ÀÛ¿ë
  • affinity chromatography
    ģȭũ·Î¸¶Åä±×·¡ÇÇ
  • column chromatography
    ¿øÅëÅ©·Î¸¶Åä±×·¡ÇÇ
  • chromatography
    Å©·Î¸¶Åä±×·¡ÇÇ
  • gas-liquid chromatography
    °¡½º¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • gel-permeation chromatography
    °ÖÅõ°úÅ©·Î¸¶Åä±×·¡ÇÇ
  • gas chromatography
    °¡½ºÅ©·Î¸¶Åä±×·¡ÇÇ
  • high-performance liquid chromatography
    °í¼º´É¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • high-pressure liquid chromatography
    °í¾Ð¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • hydrophobic chromatography
    ¼Ò¼ö¼ºÅ©·Î¸¶Åä±×·¡ÇÇ
  • ion exchange chromatography
    À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
  • liquid chromatography
    ¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • paper chromatography
    ¿©°úÁöÅ©·Î¸¶Åä±×·¡ÇÇ
  • partition chromatography
    ºÐ¹èÅ©·Î¸¶Åä±×·¡ÇÇ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chromatography
    Å©·Î¸¶Åä±×·¡ÇÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • receptor-ligand interaction
    ¼ö¿ëü¹èÀ§ÀÚ»óÈ£ÀÛ¿ë
  • affinity chromatography
    ģȭũ·Î¸¶Åä±×·¡ÇÇ
  • chromatography
    Å©·Î¸¶Åä±×·¡ÇÇ
  • column chromatography
    ¿øÅëÅ©·Î¸¶Åä±×·¡ÇÇ
  • gas chromatography
    °¡½ºÅ©·Î¸¶Åä±×·¡ÇÇ
  • gel-permeation chromatography
    °ÖÅõ°úÅ©·Î¸¶Åä±×·¡ÇÇ
  • high-performance liquid chromatography
    °íÀÛÀ§¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • high-pressure liquid chromatography
    °í¾Ð·Â¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • hydrophobic chromatography
    ¼Ò¼ö¼ºÅ©·Î¸¶Åä±×·¡ÇÇ
  • ion exchange chromatography
    À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
  • liquid chromatography
    ¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • paper chromatography
    Á¾ÀÌÅ©·Î¸¶Åä±×·¡ÇÇ
  • partition chromatography
    ºÐ¹èÅ©·Î¸¶Åä±×·¡ÇÇ
  • thin-layer chromatography
    ¹ÚÃþÅ©·Î¸¶Åä±×·¡ÇÇ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Ligand-gated channels
    ¸®°£µå°ü¹®(¡­Î¼Ú¦) ÀÌ¿ÂÅë·Î(¡­÷×ÖØ)
  • receptor-ligand interaction
    ¼ö¿ëü-¹èÀ§ÀÚ »óÈ£ÀÛ¿ë
  • GLC= gas liquid chromatography
    °¡½º¾×üũ·Î¸¶Åä±×·¡ÇÇ.
  • affinity chromatography
    ģȭ(öÑûú) Å©·Î¸¶Åä±×¶óÇÇ.
  • affinity chromatography
    ģȭ¼º Å©·Î¸¶Åä±×·¡ÇÇ
  • anion exchange chromatography
    À½À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
  • gas chromatography
    °¡½ºÅ©·Î¸¶Åä±×·¡ÇÇ
  • gas liquid chromatography =GLC
    °¡½º¾×üũ·Î¸¶Åä±×·¡ÇÇ.
  • gel-permeation chromatography
    °ÖÅõ°úÅ©·Î¸¶Åä±×·¡ÇÇ
  • high-performance liquid chromatography
    °íÀÛÀ§(íÂêÓ)¾×üũ·Î¸¶Åä±×¶óÇÇ
  • high-pressure liquid chromatography
    °í¾Ð·Â¾×ü Å©·Î¸¶Åä±×¶óÇÇ
  • hydrophobic chromatography
    ¼Ò¼ö¼º Å©·Î¸¶Åä±×·¡ÇÇ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cell growth,ligand receptor binding
    ¸®°£µå¼ö¿ë±â°áÇÕ (¡­áôé»ÐïÌ¿ùê)
  • ligand
    ¹èÀ§ÀÚ, ¸®°£µå
  • receptor-ligand interaction
    ¼ö¿ëü-¹èÀ§ÀÚ »óÈ£ÀÛ¿ë
  • affinity chromatography
    ģȭ(öÑûú) Å©·Î¸¶Åä±×¶óÇÇ.
  • affinity chromatography
    ģȭ¼º Å©·Î¸¶Åä±×·¡ÇÇ
  • anion exchange chromatography
    À½À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
  • cation exchange chromatography
    ¾çÀ̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
  • chromatography
    Âø»öÁ¶¿µ¼ú
  • column chromatography
    Ä®·³ Å©·Î¸¶Åä±×¶óÇÇ
  • column chromatography
    ¿øÅë Å©·Î¸¶Åä±×·¡ÇÇ.
  • gas chromatography
    °¡½ºÅ©·Î¸¶Åä±×·¡ÇÇ
  • gas liquid chromatography =GLC
    °¡½º¾×üũ·Î¸¶Åä±×·¡ÇÇ.
  • gel-permeation chromatography
    °ÖÅõ°úÅ©·Î¸¶Åä±×·¡ÇÇ
  • high-performance liquid chromatography
    °íÀÛÀ§(íÂêÓ)¾×üũ·Î¸¶Åä±×¶óÇÇ
  • high-pressure liquid chromatography
    °í¾Ð·Â¾×ü Å©·Î¸¶Åä±×¶óÇÇ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ligand chromatography
    ¸®°£µå Å©·Î¸¶Åä±×·¡ÇÇ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ligand-exchange chromatography
    ¸®°£µå±³È¯(Îßüµ) Å©·Î¸¶Åä±×¶óÇÇ
  • hard ligand
    °æ(Ìã)¶óÀ̰£µå
  • ligand
    ¸®°£µå
  • ligand field theory
    ¸®°£µåÀå(íÞ) ÀÌ·Ð(ìµÖå)
  • ligand-gated channel
    ¸®°£µå °ü¹®Åë·Î(μڦ÷×ÖØ)
  • ligand-induced endocytosis
    ¸®°£µåÀ¯µµ(ë¯Óô) ¼¼Æ÷³»À¯ÀÔ(á¬øàÒ®×µìý)
  • ligand-receptor internalization
    ¸®°£µå-¼ö¿ëü(áôé»ô÷) ³»ÀÔ(Ò®ìý)
  • monodentate ligand
    ÇÑÀÚ¸®¸®°£µå
  • soft ligand
    ¿¬(æã)¸®°£µå
  • adsorption chromatography
    ÈíÂø(ýåó·)Å©·Î¸¶Åä±×·¡ÇÇ
  • affinity chromatography
    ģȭ(öÑûú)Å©·Î¸¶Åä±×·¡ÇÇ
  • argentation chromatography
    ÀºÈ­(ëÞûù) Å©·Î¸¶Åä±×·¡ÇÇ
  • ascending chromatography
    »óÇà(ß¾ú¼)Å©·Î¸¶Åä±×·¡ÇÇ
  • carrier displacement chromatography
    ij¸®¾î ġȯ(öÇüµ) Å©·Î¸¶Åä±×·¡ÇÇ
  • centrifugal partition chromatography
    ¿ø½ÉºÐ¹è(êÀãýÝÂÛÕ) Å©·Î¸¶Åä±×·¡ÇÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HPLC high-performance liquid chromatography; high-power liquid chromatography; high-pressure liquid chrom...
CLD chloride diarrhea; chronic liver disease; chronic lung disease; congenital limb deficiency; crystal ...
MLC minimum lethal concentration; mixed leukocyte culture; mixed ligand chelate; mixed lymphocyte concen...
MLCT metal-to-ligand charge transfer
CCCC centrifugal countercurrent chromatography
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RP-HPLC chromatography and reversed-phase high-performance liquid chromatography
APO2L AP02 ligand
CD30L CD30 ligand
CD40L CD40 Ligand
CD40L CD40-CD40 ligand
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • endogenous ligand
    ³»Àμº ¹èÀ§ÀÚ
  • ligand receptor binding
    ¸®°£µå ¼ö¿ë±â °áÇÕ
  • affinity chromatography
    ģȭ¼º Å©·Î¸¶Åä±×·¡ÇÇ
    ģȭ¼ºÀ» ÀÌ¿ëÇÏ¿© ƯÁ¤ ¹°ÁúÀ» ¿ë¾× ¼Ó¿¡¼­ ºÐ¸®ÇÏ´Â Å©·Î¸¶Åä±×·¡ÇÇ. Ç׿ø-Ç×ü, ±âÁú-È¿¼Ò, µ¶¼Ò-µ¶¼Ò°¡ °áÇÕÇÏ´Â ¼ö¿ëü, lectin-lectin °áÇÕ¼ö¿ëü µîÀÇ ÇÑÆíÀ» ºÒ¿ë¼ºÀÇ ´ãü¿¡ °øÀ¯°áÇÕ½Ã۰í À̰Ͱú ºÐ¸®ÇÏ°í ½ÍÀº ¿ë¾×À» ¹ÝÀÀ½ÃÄÑ Àß ¼¼Á¤Çϸé ģȭ¼ºÀÌ ³ôÀº ¹°Áú¸¸ÀÌ °áÇÕÇϹǷΠ½Å¼ÓÇÏ°Ô ¿øÇÏ´Â ¹°ÁúÀ» È¿À²ÀûÀ¸·Î ²ø¾î³¾ ¼ö ÀÖ´Ù.
  • anion exchange chromatography
    À½À̿ ±³È¯ Å©·Î¸¶Åä±×·¡ÇÇ
  • chromatography
    Âø»ö Á¶¿µ¼ú, Å©·Î¸¶Åä±×·¡ÇÇ
    È­ÇÐ ºÐ¼®ÀÇ ÇÑ ¹æ¹ý. ºÐ¼®µÇ´Â ¿ë¾×À» ÈíÂøÁ¦¸¦ ³Ö¾î ¼¼¿î À¯¸®°ü¿¡ ºÎÀ¸¸é °¢°¢ÀÇ ¿ë¾×Àº °íÁ¤»ó¿¡ ´ëÇÑ ÈíÂøµµ¿¡ µû¶ó¼­ ´Ù¸¥ ¼Óµµ·Î Åë°ú À̵¿ÇÏ¿©, ÈíÂø Ä®·³ÀÇ ´Ù¸¥ ³ôÀÌÀÇ »ö´ë¸¦ »ý¼ºÇÑ´Ù. ÀÌ ¸»Àº Ä®·³¿¡ »öÃþÀ» »ý¼ºÇÏÁö ¾Ê´Â °æ¿ì¿¡µµ, °°Àº ¿ø¸®¸¦ ÀÌ¿ëÇÏ´Â ´Ù¸¥ ¹æ¹ýµµ Æ÷ÇÔÇÏ¿© È®´ëÇØ¼­ »ç¿ëµÈ´Ù. Ä«¿Ã¸°, ¾Ë·ç¹Ì³ª, ½Ç¸®Ä«, Ȱ¼ºÅºÀÌ ÈíÂøÁ¦·Î¼­ »ç¿ëµÇ°í ÀÖ´Ù. Å©·Î¸¶Åä±×·¡ÇÇ´Â »ç¿ëµÇ´Â ÈíÂøÁ¦ÀÇ ¼ºÁú, °íÁ¤»óÀÇ ¹°¸®ÇÐÀû Ư¼º ȤÀº »ç¿ëµÇ´Â ¹æ¹ý µî¿¡ µû¶ó¼­ ºÐ·ùµÈ´Ù.
  • co-chromatography
    º¸Á¶ »öÃþ ºÐ¼®
  • column chromatography
    Ä®·³ Å©·Î¸¶Åä±×¶óÇÇ
  • paper chromatography
    ÆäÀÌÆÛ Å©·Î¸¶Åä±×·¡ÇÇ
    ÈíÂø Ä®·³´ë½Å ÈíÃëÁö³ª º¸ÅëÀÇ ¿©°úÁö¸¦ »ç¿ëÇÏ´Â Å©·Î¸¶Åä±×·¡ÇÇ. °¢ ¼ººÐÀÌ °¢°¢ ´Ù¸¥ À̵¿ ¼Óµµ¿¡ ÀÇÇØ¼­ ºÐ¸®µÈ ÈÄ °¡½Ã Å©·Î¸¶Åä±×·¥ÀÌ ¸¸µé¾îÁø´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ambident ligand <chemistry> A ligand that can donate electrons through two or more atoms on their molecule.
(05 Feb 1998)
cyanocobalamin beta-ligand transferase <enzyme> Cytosolic enzyme utilizing fad, NADPH and reduced glutathione; forms glutathionylcobalamin from cyanocobalamin
Registry number: EC 2.5.1.-
Synonym: ccbl transferase
(26 Jun 1999)
ELAM-1 ligand fucosyltransferase <enzyme> Directs the expression of an elam-1 ligand; an alpha(1,3) fucosyltransferase
Registry number: EC 2.4.1.-
Synonym: elft protein, elft gene product
(26 Jun 1999)
ligand <chemistry, immunology> Any molecule that binds to another, in normal usage a soluble molecule such as a hormone or neurotransmitter, that binds to a receptor. The decision as to which is the ligand and which the receptor is often a little arbitrary when the broader sense of receptor is used (where there is no implication of transduction of signal). In these cases it is probably a good rule to consider the ligand to be the smaller of the two thus in a lectin sugar interaction, the sugar would be the ligand (even though it is attached to a much larger molecule, recognition is of the saccharide).
(18 Nov 1997)
ligand binding site The site on a protein's surface that binds a ligand; equivalent to the active site if the ligand is the substrate of an enzyme.
(05 Mar 2000)
ligand-gated channel A class of ion channel's whose ionic permeability is regulated by cell membrane receptors that respond to specific extracellular chemical signals.
(05 Mar 2000)
ligand gated ion channel A transmembrane ion channel whose permeability is increased by the binding of a specific ligand, typically a neurotransmitter at a chemical synapse. The permeability change is often drastic, such channels let through effectively no ions when shut, but allow passage at up to 10exp7 ions sexp 1 when a ligand is bound. Recently, the receptors for both acetylcholine and GABA have been found to share considerable sequence homology, implying that there may be a family of structurally related ligand gated ion channels.
(18 Nov 1997)
ligand induced endocytosis The formation of coated pits and then coated vesicles as a consequence of the interaction of ligand with receptors, which then interact with clathrin and associated proteins (coatomers) on the cytoplasmic face of the plasma membrane and come together to form a pit. Not all coated vesicle uptake of receptors requires receptor occupancy.
(18 Nov 1997)
absorption chromatography <investigation> Techniques for separating molecules based on differential absorption and elution. Term for separation methods involving flow of a fluid carrier over a nonmobile absorbing phase.
(18 Nov 1997)
adsorption chromatography Chromatography in which separation of substances is achieved by the difference in degree of adsorption of the compounds to a stationary phase.
(05 Mar 2000)
affinity chromatography <investigation> A technique of analytical chemistry used to separate and purify a biological molecule from a mixture, based on the attraction of the molecule of interest to a particular ligand which has been previously attached to a solid, inert substance.
The mixture is passed through a column containing the ligand attached to the stationary substance, so that the molecule of interest stays within the column while the rest of the mixture continues through to the end. Then, a different chemical is flushed through the column to detach the molecule from the ligand and bring it out separately from the rest of the mixture.
(09 Feb 1998)
gas chromatography <technique> A chromatographic technique (a type of column chromatography) in which the stationary phase is solid while the mobile phase is gaseous samples.
The gaseous samples are separated based on their different adsorption ability to the solid phase.
(09 Oct 1997)
gas-liquid chromatography <technique> A chemistry lab technique, a type of column chromatography, used to separate the components of a mixed substance.
The substance is held stationary by an inert solid coated with an inert liquid which is not likely to evaporate (i.e. Is nonvolatile), while a gas (called an eluant) flows past it bringing out the components one at a time.
(09 Oct 1997)
paper chromatography <technique> Separation method in which filter paper is used as the support.
A type of chromatography in which the stationary phase is a sheet of special-grade filter paper. It is in all other aspects similar to thin-layer chromatography.
Not a very sensitive method, but historically important as one of the first methods available for separating natural compounds.
(07 Mar 2000)
gel exclusion chromatography <investigation> A lab technique, a type of column chromatography, used to separate the components of a mixture by molecular size and to collect the molecules which are larger than a certain size. It is similar to gel filtration, small molecules are slowed or trapped by the pores in the gel beads filling the column, while large molecules, too large to fit into the pores, slide past the beads and get to the bottom of the column first. at this point, the large molecules are collected. Gel exclusion refers to the maximum size of molecule which will fit into the gel bead pores, and this lab technique is used to collect the molecules in the mixture which are larger than, or excluded from, the pores.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chromatography
    »öÃþºÐ¼®
  • gas chromatography
    °¡½º Å©·Î¸¶Åä±×·¡ÇÁ¹ý(À¯±âÈ­ÇÕ¹° È¥ÇÕü ºÐ¼®¹ý) ?,
  • gas liquid chromatography
    =GAS CHROMATOGRATOGRAPHY
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á